Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest Butler

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|February 15, 2022
Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians' experiencesClaudia H Marck, Assunta Hunter, Ernest Butler, et al.
Neuropsychological Rehabilitation|January 4, 2026
Depression management in multiple sclerosis (MS) -Patient and clinician perspectives and recommendationsLisa Grech, Michelle Allan, Karen-Leigh Edward, et al.
Multiple Sclerosis and Related Disorders|June 4, 2026
Utility, validity and acceptability of survey depression and anxiety screening tools for routine multiple sclerosis clinic administrationRuby Hamer, Michelle Allan, David Skvarc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2026
Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administrationLisa Grech, Michelle Allan, David Skvarc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudyNathaniel Lizak, Suzanne Hodgkinson, Ernest Butler, et al.
Brachytherapy|August 17, 2016
Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective studyCatheryn Yashar, Deanna Attai, Ernest Butler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2022
Prediction of relapse activity when switching to cladribine for multiple sclerosisMichael Zhong, Anneke van der Walt, Mastura Monif, et al.
Therapeutic Advances in Neurological Disorders|May 5, 2021
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patientsChristopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich, et al.
Stroke|March 5, 2017
Quality of Acute Care and Long-Term Quality of Life and Survival: The Australian Stroke Clinical RegistryDominique A Cadilhac, Nadine E Andrew, Natasha A Lannin, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 26, 2021
Protocol of a randomized controlled trial investigating the effectiveness of Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS)Dominique A Cadilhac, Jan Cameron, Monique F Kilkenny, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|February 15, 2022
Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians' experiencesClaudia H Marck, Assunta Hunter, Ernest Butler, et al.
Neuropsychological Rehabilitation|January 4, 2026
Depression management in multiple sclerosis (MS) -Patient and clinician perspectives and recommendationsLisa Grech, Michelle Allan, Karen-Leigh Edward, et al.
Multiple Sclerosis and Related Disorders|June 4, 2026
Utility, validity and acceptability of survey depression and anxiety screening tools for routine multiple sclerosis clinic administrationRuby Hamer, Michelle Allan, David Skvarc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2026
Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administrationLisa Grech, Michelle Allan, David Skvarc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudyNathaniel Lizak, Suzanne Hodgkinson, Ernest Butler, et al.
Brachytherapy|August 17, 2016
Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective studyCatheryn Yashar, Deanna Attai, Ernest Butler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2022
Prediction of relapse activity when switching to cladribine for multiple sclerosisMichael Zhong, Anneke van der Walt, Mastura Monif, et al.
Therapeutic Advances in Neurological Disorders|May 5, 2021
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patientsChristopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich, et al.
Stroke|March 5, 2017
Quality of Acute Care and Long-Term Quality of Life and Survival: The Australian Stroke Clinical RegistryDominique A Cadilhac, Nadine E Andrew, Natasha A Lannin, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 26, 2021
Protocol of a randomized controlled trial investigating the effectiveness of Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS)Dominique A Cadilhac, Jan Cameron, Monique F Kilkenny, et al.
Pageof 5